A randomized, controlled trial designed to demonstrate the safety and effectiveness of the experimental device to deliver pulmonary vein isolation as a treatment for symptomatic atrial fibrillation.
- 18 to 75 years.
- paroxysmal atrial fibrillation
- failure of at least one AAD
- overall good health as established by multiple criteria
Last updated: 04/25/2013